Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Efficacy and Safety on Moringa oleifera on Blood Glucose and Lipid profile: A Meta‑analysis

    Wiraphol Phimarn1, Bunleu Sungthong2, Kittisak Wichaiyo3 Corresponding author

    1. 1Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University, Thailand.
    2. 2Pharmaceutical Chemistry and Natural Products Research Unit, Faculty of Pharmacy, Mahasarakham University, Kantharawichai, Maha Sarakham, Thailand.
    3. 3Department of Pharmacy, Somdej Hospital, Somdej Kalasin, Thailand.

    CORRESPONDENCE

    Wiraphol Phimarn

    Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University, Thailand.

    wiraphol.p@msu.ac.th

    Received: 02-07-2020; Revised: 13-08-2020; Accepted: 09-03-2021.

    Volume 17, Issue 74 · pp. 373–378 · PUBLISHED 12 July 2021 · DOI: 10.4103/pm.pm_49_20

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Objectives: The main objective of this study was to assess the effects of MO consumption on blood glucose level and lipid profile in randomized controlled trial (RCTs) and non‑RCTs. Materials and Methods: A comprehensive systematic review was performed by searching the PubMed, ScienceDirect, Scopus, and Thai Library Integrated System databases up to December 2019 without any language restrictions by two independent authors. The DerSimonian and Laird random‑effects model method was used to pool the results. Results: Seven trials with 257 participants and treatment duration of 28–90 days were included. The pooled results showed a significant reduction in fasting blood sugar (FBS; weighted mean difference [WMD]: −14.81 mg/ dL; 95% confidence interval [CI]: −27.99, −1.63; I2 = 97.8%), postprandial glucose (PPG) (WMD − 64.73 mg/dL; 95% CI: −102.87, −26.59; I2 = 93%) and no significant change in HbA1C (WMD: 0.70%; 95% CI: −1.42, 0.69; I2 = 99%), low‑density lipoprotein (WMD − 11.20 mg/dL; 95% CI: −34.12, 11.72; I2 = 8.08%), total cholesterol (WMD − 4.73 mg/dL; 95% CI: −24.96, 15.49; I2 = 80%), and triglycerides (WMD − 3.29 mg/dL; 95% CI: −9.95, 3.36; I2 = 29%). Moreover, MO treatment increased high‑density lipoprotein (HDL) level significantly (WMD 2.15 mg/dL; 95% CI: 1.92, 2.39; I2 = 0%). No serious adverse effects of the intervention were reported. Conclusion: The results of our study suggested that MO treatment decreased FBS, PPG levels and increase HDL level. However, the long‑term benefits and safety of the treatment remain to be determined.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Phimarn, W., Sungthong, B., & Wichaiyo, K. (2021). Efficacy and Safety on Moringa oleifera on Blood Glucose and Lipid profile: A Meta‑analysis. Pharmacognosy Magazine, 17(74), 373–378. https://doi.org/10.4103/pm.pm_49_20